Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. (AIMT) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 326 transactions totaling $2.3B, demonstrating a bullish sentiment with $2.2B in net insider flow. The most recent transaction on Oct 13, 2020 involved a transaction of 7,840 shares valued at $270.5K.
AIMT Insider Activity Summary
Who Is Buying AIMT Stock?
No significant insider buying has been recorded for AIMT in the recent period.
Who Is Selling AIMT Stock?
No significant insider selling has been recorded for AIMT in the recent period.
Is Aimmune Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AIMT is bullish with an Insider Alignment Score of 98/100 and a net flow of $2.2B. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AIMT Frequently Asked Questions
Understanding AIMT Insider Activity
Insider trading at Aimmune Therapeutics, Inc. (AIMT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading AIMT stock, having executed 326 transactions in the past 90 days. The most active insider is Des Produits Nestle S.a. Societe (Executive), who has made 2 transactions totaling $1.9B.
Related Tools
Track Aimmune Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AIMT file new Form 4 transactions